FDA`s indecision keeps Acomplia away from US shores

Released on = December 15, 2006, 9:42 pm

Press Release Author = Jack White

Industry = Healthcare

Press Release Summary = Though Acomplia has not been approved for sale in the US by
FDA as of yet, the manufacturer of it, Sanofi-Aventis is contemplating its approval
in near future.

Press Release Body = Though Acomplia has not been approved for sale in the US by FDA
as of yet, the manufacturer of it, Sanofi-Aventis is contemplating its approval in
near future. The FDA is not happy with the clinical trials done for Acomplia as a
treatment for having weight loss. And it is the reason why, its introduction in the
US market is postponed. The manufacturer of it is pitching that the UK has given
approval for sale of the drug but the Americans are being denied of using this diet
pill by the FDA.

On the prolonged wait for Acomplia in the US, Dr. Samuel Griffith remarked \"Obese in
the US are losing a great opportunity as they are unable to find a drug that can
really work like Acomplia. The FDA's inability to say yes or no to the drug is
keeping the introduction of the drug the US hanging in the fire.\"

The above statement from Dr. Griffith is an important statement as that makes FDA
guilty of lengthening the approval process of the drug. While many obese individuals
in the UK are benefiting from the drug, the obese individuals in the US are being
denied of that facility.

Acomplia Rimonabant is an online drug store that deals in Acomplia weight loss drug.
One needs to have a prescription for this drug. If one does not have the required
finances or ability to avail prescription for it from a doctor, he or she can get a
free online prescription from a number of online sources.

Refer to http://www.acompliarimonabant.co.uk if you wish to find more information on
Acomplia.

Web Site = http://www.acompliarimonabant.co.uk

Contact Details = Kelton House,
London Road,
East Grinstead,
West Sussex,
RH19 1HH
UK
Telephone: 01342 375 900
email : jackwhiter@gmail.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •